Recent data from the National Bureau of Statistics of China showed that, according to preliminary calculations, China's gross domestic product (GDP) grew by 4.8% year-on-year in the first three quarters of this year, with the overall operation of the national economy remaining stable with progress.
Against the backdrop of sluggish global economic growth, escalating geopolitical conflicts, and a volatile international trade environment, the Chinese economy continues to demonstrate resilience and potential.
Faced with a complex and severe external environment, the Chinese government has successively introduced a package of incremental policies, which cover multiple fields such as finance, consumption, investment, real estate, and stock market, effectively boosting confidence from all parties and promoting the positive development of the Chinese economy.
China continues to deepen reforms, expand high-level opening up to the outside world, increase policy support, continuously optimize the business environment, cultivate and strengthen new driving forces, enhance economic resilience, and bring more development opportunities to multinational enterprises.
Foreign enterprises in China continue to expand their investment scale in China, demonstrating through practical actions that the attractiveness of the Chinese market remains strong.
In August of this year, global pharmaceutical giant AstraZeneca of the UK once again increased its capital to build a global production and supply base for inhalation aerosols in Qingdao, Shandong.
This is the second capital increase since AstraZeneca officially announced its investment in the new Qingdao production and supply base in March 2023, bringing the cumulative investment amount of the project to $750 million.
Over the years, AstraZeneca has continuously increased its investment in Chinese manufacturing, with a cumulative total exceeding $2 billion, fully demonstrating its confidence and determination to deeply engage in China's development.
In the past five years, the return on foreign direct investment in China has been about 9%, which is at a relatively high level internationally.
For multinational enterprises, the Chinese market is not only an innovation base, but also provides inspiration for more consumer sectors.
Recently, the Chinese government has introduced a series of policies that signal China's continuous optimization of the business environment and sharing of market opportunities, further strengthening the confidence and determination of foreign-funded enterprises to invest in China.
In September of this year, China released the "Special Management Measures for Foreign Investment Access (Negative List) 2024 Edition," which comprehensively lifted restrictions on foreign investment access in the manufacturing sector, demonstrating China's firm determination to expand high-level opening-up to the outside world.
In the medical field, China will clearly carry out pilot work to expand opening up, including plans to allow the establishment of wholly foreign-owned hospitals in multiple locations.
Currently, the Chinese economy has deeply integrated into the world, and China's development has benefited greatly from economic globalization.
The process of economic globalization also cannot be separated from the development of the Chinese economy.
No matter how the international situation changes, China's determination to expand high-level opening-up to the outside world will remain unchanged, as will its commitment to promoting economic globalization in a more open, inclusive, balanced, and win-win direction.
LiuQing is a reporter from China Global Television Network (CGTN)